Litcius/Paper detail

First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial

Judith A. Stibbe, Hilda A. de Barros, Daan G. J. Linders, Shadhvi S. Bhairosingh, Elise M. Bekers, Pim J. van Leeuwen, Philip S. Low, Sumith A. Kularatne, Alexander L. Vahrmeijer, Jacobus Burggraaf, Henk G. van der Poel

2023The Lancet Oncology54 citationsDOIOpen Access PDF

Topics & Concepts

MedicineProstatectomyProstate cancerGlutamate carboxypeptidase IIUrologyCohortLymph nodeProstateProstate-specific antigenCancerSurgeryInternal medicineProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer Research and Treatments
First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial | Litcius